Powered by

OncoMed Pharmaceuticals to Report Fourth Quarter and Year End Financial Results on March 8, 2017

Mar 01, 2017 - GlobeNewswire

REDWOOD CITY, Calif., March 01, 2017 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (Nasdaq:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer stem cell and immuno-oncology therapeutics, will announce financial results on Wednesday, March 8, 2017.  Paul J. Hastings, Chairman and Chief Executive Officer, will host a conference call to review 2016 fourth quarter and full-year results and recent corporate events beginning at 4:30 p.m. Ea...